ClinicalTrials.gg

Nuvalent Inc. clinical trials

Acquired by GlaxoSmithKline, Jul 15, 2026 · source ↗

The registry lists 6 studies whose lead sponsor is Nuvalent Inc. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.

Before and after it joined GlaxoSmithKline

First submitted before Nuvalent Inc. became part of GlaxoSmithKline
6
First submitted after Nuvalent Inc. became part of GlaxoSmithKline
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Coming up

1 of Nuvalent Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 6 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now467%
  • Status unknown or other233%

Phase

  • Phase 13
  • Phase 22
  • Phase 31

Where

  • Canada6
  • Australia6
  • United States5
  • France5
  • Singapore5
  • Italy5

Over the years

  1. 222
  2. 23
  3. 24
  4. 25
  5. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Nuvalent Inc.6 studies

Something wrong with this grouping? Tell us on the GlaxoSmithKline page.

Studies

Recruiting first, then most recently updated. Showing 6 of 6. All GlaxoSmithKline studies →